It seems, however, that the increase of the copeptin plasma concentration in patients with chronic kidney disease was probably not related to the progression of CKD, but most likely related to other pathologies, including chronic heart failure and diabetes types 1 and 2 [25–27]. Here, AVP is linked to type 1 diabetes mellitus.